Bluebird Bio: Funding, Investors & Team (Oct 2026)
Bluebird bio is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company's gene therapy procedures aim to genetically modify a patient's cells to fundamentally correct or address the genetic basis underlying a disease. Bluebird's revenue is derived from collaboration arrangements, research fees, license fees, and grant revenue. The company works with industry peers, strategic partners, and nonprofit organizations for the development and commercialization of its product candidates.
Bluebird Bio has raised $75.0M across 2 funding rounds on record, the most recent an undisclosed round announced in Feb 2025.
Bluebird Bio Company Profile and Key Stats
Latest funding round on record: Feb 2025.
Bluebird Bio Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Bluebird Bio raised $75.0M in a Post-IPO Equity announced in Sep 2021.
3.4 years later, an undisclosed round was announced in Feb 2025 with no disclosed amount.
Bluebird Bio Founders and Leadership Team
Contact details for the Bluebird Bio team: 1 of 2 have an email address on file.
Start 14-day free trial →Bluebird Bio Funding Compared to Other Biotechnology Startups
Funded Startups Like Bluebird Bio in Biotechnology and Somerville
Companies Similar to Bluebird Bio
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Bluebird Bio Funding FAQs
What does Bluebird Bio do?
Bluebird bio is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company's gene therapy procedures aim to genetically modify a patient's cells to fundamentally correct or address the genetic basis underlying a disease. Bluebird's revenue is derived from collaboration arrangements, research fees, license fees, and grant revenue. The company works with industry peers, strategic partners, and nonprofit organizations for the development and commercialization of its product candidates.
How much funding has Bluebird Bio raised?
Bluebird Bio has raised $75.0M across 2 rounds on record.
When did Bluebird Bio last raise funding?
Bluebird Bio's most recent funding round on record was announced in Feb 2025. The amount was not disclosed.
Who founded Bluebird Bio?
FundedIQ lists Philippe Leboulch (Founder) at Bluebird Bio.
Who is the CEO of Bluebird Bio?
Nick Leschly is listed as CEO at Bluebird Bio.
Where is Bluebird Bio headquartered?
Bluebird Bio is based in Somerville, Massachusetts, United States.
How many employees does Bluebird Bio have?
Bluebird Bio is in the 251-500 employee band.
About FundedIQ's Bluebird Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Bluebird Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.